Instituto de Investigación Biosanitaria de Granada (ibs.GRANADA), 18016 Granada, Spain; Clinical Laboratory Management Unit, San Cecilio University Hospital, 18016 Granada, Spain.
Instituto de Investigación Biosanitaria de Granada (ibs.GRANADA), 18016 Granada, Spain; Biomedical Research Centre (CIBM), University of Granada, 18100 Granada, Spain; Department of Radiology and Physical Medicine, University of Granada, 18071 Granada, Spain.
Sci Total Environ. 2024 Nov 15;951:175593. doi: 10.1016/j.scitotenv.2024.175593. Epub 2024 Aug 22.
Perfluoroalkyl substances (PFAS) are environmental contaminants present in a wide range of consumer products and frequently detected in drinking water. They have been linked to adverse reproductive health outcomes in women, but there is limited human evidence on the association of PFAS exposure with endometriosis.
OBJECTIVE/AIM: To explore the association between plasma concentrations of several PFAS, considered individually and as a mixture, and the risk of endometriosis in women of childbearing age.
Between 2018 and 2020, 42 patients with endometriosis and 90 controls undergoing abdominal surgery were recruited at two public hospitals in Granada, Spain. The presence or absence of endometriosis was ascertained by laparoscopic inspection of the pelvis and biopsy of suspected lesions (histological diagnosis). Concentrations of 10 PFAS were quantified in plasma samples from participants. Unconditional logistic regression was employed to examine associations of individual PFAS and summed concentrations of short (∑SC) and long-chain (∑LC) PFAS with odds of endometriosis, and quantile g-computation was used to assess their mixture effect.
In models adjusted for age, schooling, and parity, perfluorotridecanoic acid (PFTrDA) was associated with higher odds of endometriosis (odds ratio [OR] = 1.74; 95 % CI = 1.11-2.73 per 2-fold increase in plasma concentrations), while marginally significant associations were found for perfluorohexane sulfonate (PFHxS) (OR = 1.45, 95 % CI = 0.94-2.21) and ∑SC PFAS (OR = 1.48; 95 % CI = 0.96-2.30). No associations were found for the remaining PFAS. The PFAS mixture was non-significantly associated with 1.7-fold higher odds of endometriosis (95 % CI = 0.73-3.80), with perfluorononanoic acid (PFNA), PFHxS, and PFTrDA being the major contributors to this effect.
These findings suggest that exposure to certain PFAS may increase the odds of endometriosis. However, given the modest sample size, further studies are warranted to verify these results.
全氟烷基物质(PFAS)是存在于各种消费品中的环境污染物,经常在饮用水中检测到。它们与女性不良生殖健康结果有关,但关于 PFAS 暴露与子宫内膜异位症之间的关联,人类证据有限。
目的/目标:探讨几种 PFAS 的血浆浓度,分别考虑和作为混合物,与生育年龄妇女子宫内膜异位症风险之间的关联。
2018 年至 2020 年,在西班牙格拉纳达的两家公立医院,招募了 42 名子宫内膜异位症患者和 90 名接受腹部手术的对照组。通过腹腔镜检查骨盆和可疑病变的活检(组织学诊断)来确定子宫内膜异位症的存在或不存在。对参与者的血浆样本进行了 10 种 PFAS 的浓度定量。采用非条件逻辑回归分析个体 PFAS 和短链(∑SC)和长链(∑LC)PFAS 总和浓度与子宫内膜异位症的比值比(OR)的关联,并采用分位数 g 计算评估其混合物效应。
在调整年龄、教育程度和产次的模型中,全氟十三烷酸(PFTrDA)与子宫内膜异位症的更高几率相关(OR = 1.74;95%CI = 1.11-2.73,血浆浓度增加 2 倍),而过氟己烷磺酸(PFHxS)(OR = 1.45,95%CI = 0.94-2.21)和∑SC PFAS(OR = 1.48;95%CI = 0.96-2.30)的相关性则略有意义。其他 PFAS 则没有相关性。PFAS 混合物与子宫内膜异位症 1.7 倍的几率呈非显著相关(95%CI = 0.73-3.80),全氟壬酸(PFNA)、PFHxS 和 PFTrDA 是该效应的主要贡献者。
这些发现表明,接触某些 PFAS 可能会增加子宫内膜异位症的几率。然而,由于样本量较小,需要进一步的研究来验证这些结果。